Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been significant developments in their design, the most notable of which has been the introduction of drug-eluting stents. This paper reviews the benefits, risks, and current status of Food and Drug Administration-approved drug-eluting stents.
Garg et al. (2010) studied this question. Drug-eluting stents represent the most notable development in coronary artery stents, offering significant benefits alongside specific risks in modern interventional cardiology.